Hypogonadotropic Hypogonadism 8 With Or Without Anosmia C3553841
A genetic disorder where hormone signals from the brain to the gonads are disrupted, affecting development and fertility. Can include smell loss. Treated with hormone replacement.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Anosmia
(ENT)Fatigue or weight changes
(endocrine)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Delayed puberty
(Endocrine)Infertility
(Reproductive)Micropenis
(Reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Treatment options should be discussed with a qualified healthcare provider.
Letrozole Aromatase Inhibitor Therapy
Aromatase inhibitor therapy to reduce estrogen conversion and increase endogenous gonadotropin stimulation of gonads.
Combined Gonadotropin Replacement
Combination therapy with hCG and recombinant FSH/LH to maximally stimulate gonadal function and optimize fertility outcomes.
Additional treatment options
Fertility Preservation Procedures
Sperm banking or oocyte/embryo cryopreservation for patients undergoing treatment that may compromise future fertility.
procedureLongitudinal Growth and Development Tracking
Regular assessment of growth parameters, bone age, and pubertal progression in pediatric and adolescent patients.
monitoringStress Reduction and Mind-Body Practices
Incorporation of yoga, meditation, and mindfulness practices to reduce stress-related suppression of hypothalamic function.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Hypogonadotropic Hypogonadism 8 With Or Without Anosmia C3553841?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus on the diagnosis and treatment of congenital hypogonadotropic hypogonadism. Endocr Rev. 2022.
Mayer JS, Pedersen-White HG, Quinton R. Genetics of hypogonadotropic hypogonadism and olfactory bulb agenesis. Mol Cell Endocrinol. 2020.
Sidhoum VF, Chan YM, Lippincott MF, et al. Reversible and irreversible hypogonadotropic hypogonadism: clinical spectrum and treatment outcomes. J Clin Endocrinol Metab. 2019.
Cangiano B, Swee DS, Quinton R, Bonomi M. Genetics of combined pituitary hormone deficiency and olfactory impairment: a systematic review. Eur J Endocrinol. 2021.
Medication Comparisons
Compare medications used to treat Hypogonadotropic Hypogonadism 8 With Or Without Anosmia C3553841. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy